Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Kidney Cancer
Related studies linked through entity extraction aliases.
Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery
- Status
- TERMINATED
- Phase
- PHASE2
Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses.
- Status
- COMPLETED
- Phase
- PHASE1
Treatment of Patients With Advanced Renal Cancer With a Radiolabeled Antibody, Yttrium-90 Conjugated Chimeric G250
- Status
- COMPLETED
- Phase
- PHASE1
OSI-774 and Bevacizumab in the Treatment of Patients With Metastatic Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE3
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Neoadjuvant Clinical Trial to Evaluate the Efficacy of Bevacizumab for Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Sequential ATRA Then IL-2 for Modulation of Dendritic Cells and Treatment of Metastatic Renal Cell Cancer
- Status
- COMPLETED
- Phase
- PHASE2
NGR-TNF in Treating Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Vaccine Therapy in Treating Patients With Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Lenalidomide in Treating Patients With Advanced or Unresectable Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Vaccine Therapy With or Without Fludarabine in Treating Patients With Stage IV Kidney Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer
- Status
- COMPLETED
- Phase
- PHASE2
PEG-Interferon Alfa-2b, Sargramostim, and Thalidomide in Treating Patients With Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Vaccine Treatment of Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced Unresectable or Metastatic Kidney Cancer
- Status
- TERMINATED
- Phase
- PHASE2
DNA Variations in the Gene in Young Patients With Wilms' Tumor
- Status
- COMPLETED
- Phase
- N/A
17AAG to Treat Kidney Tumors in Von Hippel-Lindau Disease
- Status
- COMPLETED
- Phase
- PHASE2